Creative Medical Technology Holdings Inc (CELZ) is now in the Fair zone, suggesting that its current forward PS ratio of 8605.62 is considered Fairly compared with the five-year average of -1.42. The fair price of Creative Medical Technology Holdings Inc (CELZ) is between 0.20 to 1.84 according to relative valuation method.

Relative Value

Fair Zone

0.20-1.84

Current Price：1.79

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Creative Medical Technology Holdings Inc (CELZ) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Creative Medical Technology Holdings Inc (CELZ) has a current Price-to-Book (P/B) ratio of 0.91. Compared to its 3-year average P/B ratio of 0.72, the current P/B ratio is approximately 25.79% higher. Relative to its 5-year average P/B ratio of -3.43, the current P/B ratio is about -126.54% higher. Creative Medical Technology Holdings Inc (CELZ) has a Forward Free Cash Flow (FCF) yield of approximately -85.24%. Compared to its 3-year average FCF yield of -107.07%, the current FCF yield is approximately -20.39% lower. Relative to its 5-year average FCF yield of -77.12%, the current FCF yield is about 10.53% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for CELZ competitors is 1722.57, providing a benchmark for relative valuation. Creative Medical Technology Holdings Inc Corp (CELZ.O) exhibits a P/S ratio of 8605.62, which is 399.58% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of CELZ increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of CELZ in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CELZ currently overvalued or undervalued?

What is Creative Medical Technology Holdings Inc (CELZ) fair value?

CELZ's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Creative Medical Technology Holdings Inc (CELZ) is between 0.20 to 1.84 according to relative valuation method.

How does CELZ's valuation metrics compare to the industry average?

The average P/S ratio for CELZ's competitors is 1722.57, providing a benchmark for relative valuation. Creative Medical Technology Holdings Inc Corp (CELZ) exhibits a P/S ratio of 8605.62, which is 399.58% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Creative Medical Technology Holdings Inc (CELZ) as of Mar 02 2026?

As of Mar 02 2026, Creative Medical Technology Holdings Inc (CELZ) has a P/B ratio of 0.91. This indicates that the market values CELZ at 0.91 times its book value.

What is the current FCF Yield for Creative Medical Technology Holdings Inc (CELZ) as of Mar 02 2026?

As of Mar 02 2026, Creative Medical Technology Holdings Inc (CELZ) has a FCF Yield of -85.24%. This means that for every dollar of Creative Medical Technology Holdings Inc's market capitalization, the company generates -85.24 cents in free cash flow.

What is the current Forward P/E ratio for Creative Medical Technology Holdings Inc (CELZ) as of Mar 02 2026?

As of Mar 02 2026, Creative Medical Technology Holdings Inc (CELZ) has a Forward P/E ratio of -1.26. This means the market is willing to pay $-1.26 for every dollar of Creative Medical Technology Holdings Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Creative Medical Technology Holdings Inc (CELZ) as of Mar 02 2026?

As of Mar 02 2026, Creative Medical Technology Holdings Inc (CELZ) has a Forward P/S ratio of 8605.62. This means the market is valuing CELZ at $8605.62 for every dollar of expected revenue over the next 12 months.

CELZ Valuation